Cascadian Therapeutics (CASC)

[io_io]

Complete Paper - Phase IIb Trial in NSCLC Stage IIIB and IV


Usually these papers cost $100 or more - strangely enough this one is entirely free (you can also click on the PDF option) -

http://jco.ascopubs.org/cgi/content/full/23/27/6674

This is of course the famous pIIb trial where Stimuvax had the very impressive results -

"Survival results indicate that the median overall survival time for patients in the L-BLP25 arm was 17.4 months compared with 13 months for patients in the BSC arm"

"The greatest difference in survival was observed in stage IIIB LR patients (adjusted HR = 0.524; 95% CI, 0.261 to 1.052; P = .069)"